Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
1,500,395
-
Shares change
-
+43,082
-
Total reported value, excl. options
-
$62,744,601
-
Value change
-
+$2,563,590
-
Put/Call ratio
-
11.9%
-
Number of buys
-
31
-
Number of sells
-
-19
-
Price
-
$41.83
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2020
63 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q2 2020.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,500,395 shares
.
Largest 10 shareholders include MORGAN STANLEY (228,584 shares), UBS Group AG (204,198 shares), BANK OF AMERICA CORP /DE/ (198,862 shares), WELLS FARGO & COMPANY/MN (160,055 shares), NTV Asset Management LLC (75,428 shares), ROYAL BANK OF CANADA (66,780 shares), Cardan Capital Partners, LLC (57,584 shares), COMMONWEALTH EQUITY SERVICES, LLC (55,094 shares), ADVISOR GROUP HOLDINGS, INC. (50,862 shares), and NWAM LLC (46,846 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.